VIREAD Safety Questions, VIREAD Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about VIREAD. Our extensive database of VIREAD adverse events and VIREAD warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about VIREAD
VIREAD Safety Reports
Total VIREAD reports: 183.VIREAD FDA safety alerts: 2003 .
Reported deaths: 9 Reported hospitalizations: 78.
Take VIREAD Side Effects Survey or Share Your VIREAD Story. VIREAD Usage.
Showing 1-75 of 183 Next >
Consumer or non-health professional from UNITED STATES reported VIREAD problem on May 08, 2007. Female patient, 35 years of age, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. VIREAD dosage: unknown. During the same period patient was treated with COMBIVIR. Patient recovered.VIREAD problem was reported by a Consumer or non-health professional from UNITED STATES on May 10, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: pregnancy, ultrasound antenatal screen abnormal. VIREAD dosage: unknown. During the same period patient was treated with LAMIVUDINE, LOPINAVIR. Patient recovered.
Physician from GERMANY reported VIREAD problem on Apr 23, 2007. Female patient, weighting 165.3 lb, was diagnosed with hiv infection, polyneuropathy, osteoporosis and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, osteoporosis, proteinuria. VIREAD dosage: unknown. During the same period patient was treated with EPIVIR, REYATAZ, GABAPENTIN, CALCIUM CHLORIDE, VITAMIN D3. Patient recovered.
VIREAD problem was reported by a Consumer or non-health professional from UGANDA on May 24, 2007. Female patient, weighting 7.50 lb, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: acrochordon. VIREAD dosage: unknown. During the same period patient was treated with COMBIVIR. Patient recovered.
Health Professional from FRANCE reported VIREAD problem on Mar 16, 2007. Male patient, 55 years of age, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: hallucination, visual. VIREAD dosage: unknown. During the same period patient was treated with KIVEXA, TRIATEC, PLAVIX, CELECTOL, LASIX, ALDACTONE, GABAPENTIN. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: pregnancy, ultrasound antenatal screen abnormal. VIREAD dosage: unknown. During the same period patient was treated with LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE AND ZIDOVUDINE, LOPINAVIR. Patient recovered.
Pharmacist from CANADA reported VIREAD problem on May 25, 2007. Male patient, weighting 117.5 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactic acid increased, blood phosphorus decreased, mitochondrial toxicity, sepsis. VIREAD dosage: unknown. During the same period patient was treated with EPIVIR, ZERIT, SUSTIVA. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Physician from FRANCE on June 04, 2007. Male patient, weighting 172.0 lb, was diagnosed with hiv infection, depression and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, asthenia, blood calcium increased, blood phosphorus increased, dialysis, haemoglobin decreased, neurological symptom, renal failure. VIREAD dosage: unknown. During the same period patient was treated with KALETRA, EPIVIR, EFFEXOR, ATARAX, LEXOMIL, TIAPRIDAL, STILNOX. Patient was hospitalized and became disabled. Patient recovered.
Health Professional from FRANCE reported VIREAD problem on June 01, 2007. Male patient, 40 years of age, weighting 119.0 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: nephrolithiasis. VIREAD dosage: unknown. During the same period patient was treated with ZIAGEN, NORVIR, REYATAZ. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Pharmacist from CANADA on June 05, 2007. Male patient, weighting 117.5 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, hyponatraemia, hypophosphataemia, lactic acidosis, mitochondrial toxicity, oesophagitis ulcerative, renal failure acute, rhabdomyolysis, sepsis. VIREAD dosage: unknown. During the same period patient was treated with EPIVIR, ZERIT, SUSTIVA, GLUCOBAY, ALDACTONE, LASIX, STATEX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported VIREAD problem on June 07, 2007. Male patient, weighting 142.1 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: renal failure, sepsis. VIREAD dosage: unknown. During the same period patient was treated with FOSCARNET. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Health Professional from FRANCE on June 08, 2007. Male patient, 46 years of age, weighting 180.8 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, skin ulcer. VIREAD dosage: unknown. During the same period patient was treated with NORVIR, EPIVIR, REYATAZ, BACTRIM, BUPRENORPHINE CHLORHYDRATE. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported VIREAD problem on June 11, 2007. Female patient, weighting 216.1 lb, was diagnosed with hepatitis b and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: fluid retention, hepatic steatosis, hypokalaemia, metabolic syndrome, renal cyst, renal failure, urinary tract infection. VIREAD dosage: unknown. During the same period patient was treated with HEPSERA, CONCOR, NOVONORM, FUROSEMIDE. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Female patient, 37 years of age, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: angioedema, dyspnoea, hypersensitivity, rash, urticaria. VIREAD dosage: unknown. Patient recovered.
Health Professional from FRANCE reported VIREAD problem on June 15, 2007. Male patient, 44 years of age, was diagnosed with hiv infection, hepatitis b virus, visceral leishmaniasis, bronchitis chronic and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: renal tubular disorder. VIREAD dosage: unknown. During the same period patient was treated with AMBISOME, EPIVIR, SYMBICORT. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2006. Female patient, 34 years of age, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: stillbirth. VIREAD dosage: unknown. During the same period patient was treated with KALETRA. Patient recovered.
Physician from GERMANY reported VIREAD problem on Apr 03, 2006. Male patient, weighting 134.5 lb, was diagnosed with hiv infection, antibiotic prophylaxis, hyperlipidaemia, coronary artery disease, cardiac failure and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: ascites, diabetes mellitus non-insulin-dependent, hepatic cirrhosis, metabolic acidosis, oedema, polyneuropathy, renal failure acute. VIREAD dosage: unknown. During the same period patient was treated with VIDEX, REYATAZ, NORVIR, COTRIM DS, CEDUR RETARD, ISMO RETARD, LASIX, ASPIRIN. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Health Professional from FRANCE on June 28, 2006. Female patient, 50 years of age, weighting 99.21 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, osteomalacia, osteoporosis, renal tubular disorder. VIREAD dosage: unknown. During the same period patient was treated with EPIVIR, SUSTIVA. Patient recovered.
Health Professional from FRANCE reported VIREAD problem on June 29, 2006. Male patient, 37 years of age, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: alpha 1 globulin increased, blood bicarbonate decreased, candida serology positive, delirium febrile, hypergammaglobulinaemia, hypoalbuminaemia, hypocalcaemia, hypocapnia. VIREAD dosage: unknown. During the same period patient was treated with CRIXIVAN, NORVIR, EPIVIR, NOVOMIX, AVLOCARDYL, AERIUS, MIANSERINE, FORTIMEL. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Health Professional from FRANCE on June 28, 2006. Female patient, 43 years of age, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, hepatomegaly, pyelonephritis acute, renal failure acute. VIREAD dosage: unknown. During the same period patient was treated with VIDEX, SUSTIVA. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported VIREAD problem on June 29, 2006. Male patient, weighting 154.3 lb, was diagnosed with hiv infection, prophylaxis and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: metabolic acidosis, pyrexia, renal failure acute, vomiting. VIREAD dosage: unknown. During the same period patient was treated with ZIAGEN, KALETRA, BACTRIM. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2006. Female patient, 25 years of age, weighting 242.4 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: congenital teratoma, pregnancy. VIREAD dosage: unknown. During the same period patient was treated with VIDEX, VIRACEPT. Patient recovered.
Health Professional from FRANCE reported VIREAD problem on July 10, 2006. Male patient, 45 years of age, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: diffuse large b-cell lymphoma, overdose. VIREAD dosage: unknown. During the same period patient was treated with VIDEX, NORVIR, FUZEON. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Pharmacist from UNITED STATES on July 18, 2006. Male patient, 40 years of age, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: dialysis, fall, nephropathy toxic, polyuria, renal failure acute, renal tubular necrosis. VIREAD dosage: 300 MG DAILY PO. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported VIREAD problem on July 12, 2006. Male patient, weighting 127.9 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: ascites, neuropathy peripheral, pleural effusion, renal failure acute. VIREAD dosage: unknown. During the same period patient was treated with TRUVADA, KALETRA, ATAZANAVIR. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Physician from FRANCE on June 13, 2006. Female patient, weighting 136.7 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: hepatitis c, hypocalcaemia, osteoarthritis. VIREAD dosage: unknown. During the same period patient was treated with SUSTIVA, EPIVIR. Patient recovered.
Physician from UNITED STATES reported VIREAD problem on Nov 28, 2005. Male patient, weighting 212.2 lb, was diagnosed with hiv infection, blood cholesterol increased and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: anaemia of chronic disease, glomerulonephritis proliferative, hydronephrosis, nephrolithiasis, renal failure acute, tubulointerstitial nephritis. VIREAD dosage: unknown. During the same period patient was treated with ABACAVIR, KALETRA, TRICOR, VIOGEN. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Health Professional from FRANCE on July 04, 2005. Male patient, 44 years of age, weighting 158.7 lb, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: angina unstable. VIREAD dosage: unknown. During the same period patient was treated with INVIRASE, NORVIR, KALETRA, BACTRIM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported VIREAD problem on June 21, 2006. Female patient, 34 years of age, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: maternal condition affecting foetus, stillbirth, twin pregnancy. VIREAD dosage: unknown. During the same period patient was treated with KALETRA. Patient recovered.
VIREAD problem was reported by a Physician from UNITED STATES on Nov 23, 2005. Male patient, weighting 170.0 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: acquired oesophageal web, alanine aminotransferase increased, aspartate aminotransferase increased, lactic acidosis, nephropathy toxic, weight decreased. VIREAD dosage: unknown. During the same period patient was treated with DIDANOSINE, VIRAMUNE, GLUCOPHAGE, ZESTORETIC. Patient recovered.
Consumer or non-health professional from UNITED STATES reported VIREAD problem on Mar 14, 2006. Female patient, 34 years of age, weighting 313.0 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: renal failure acute. VIREAD dosage: 300 MG, 1 IN 1 D, ORAL. During the same period patient was treated with COMBIVIR, KALETRA, CELEBREX, LOTENSIN, AMBIEN, BENADRYL, CALCIUM, CLARITIN. Patient recovered.
VIREAD problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2006. Female patient, 73 years of age, weighting 93.00 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: fanconi syndrome. VIREAD dosage: 300 MG, 1 IN 1 D, ORAL. During the same period patient was treated with RITONAVIR, ATAZANAVIR SULPHATE, LAMIVUDINE, ATENOLOL, ECOTRIN, PREVACID, FOSAMAX. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported VIREAD problem on June 29, 2006. Male patient, weighting 141.1 lb, was diagnosed with hiv infection, prophylaxis and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: metabolic acidosis, pyrexia, renal failure acute, vomiting. VIREAD dosage: unknown. During the same period patient was treated with ZIAGEN, LOPINAVIR, BACTRIM. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Physician from UNITED KINGDOM on July 21, 2006. Male patient, weighting 218.3 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia, hyperparathyroidism, hyperphosphaturia, vitamin d deficiency. VIREAD dosage: unknown. During the same period patient was treated with EMTRIVA, RITONAVIR, BEZOLIP MONO. Patient recovered.
Health Professional from UNITED STATES reported VIREAD problem on July 26, 2006. Female patient, 52 years of age, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: anaemia, blood alkaline phosphatase increased, fanconi syndrome acquired, osteomalacia. VIREAD dosage: unknown. During the same period patient was treated with NELFINAVIR, AZITHROMYCIN, TRIMETHOPRIM. Patient recovered.
VIREAD problem was reported by a Health Professional from FRANCE on July 04, 2006. Female patient, weighting 99.21 lb, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: bone pain, hypophosphataemia, osteomalacia, renal failure, renal tubular disorder. VIREAD dosage: unknown. During the same period patient was treated with NORVIR, EPIVIR, REYATAZ, CLIMASTON. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported VIREAD problem on Aug 03, 2006. Female patient, 35 years of age, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: hypokalaemia. VIREAD dosage: unknown. During the same period patient was treated with DIDANOSINE, KALETRA. Patient recovered.
VIREAD problem was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Male patient, 41 years of age, weighting 99.21 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: diabetes insipidus, hypokalaemia, hypophosphataemia, paralysis, renal tubular disorder, rhabdomyolysis. VIREAD dosage: unknown. During the same period patient was treated with FOSAMPRENAVIR, RITONAVIR, ABACAVIR, LAMIVUDINE, ATAZANAVIR. Patient recovered.
Health Professional from SPAIN reported VIREAD problem on Aug 07, 2006. Female patient, 39 years of age, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: hepatitis cholestatic. VIREAD dosage: unknown. During the same period patient was treated with VIRAMUNE, EPIVIR, DALACIN, IBUPROFEN, CLAMOXYL. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Health Professional from UNITED KINGDOM on Oct 03, 2005. Female patient, 31 years of age, was diagnosed with hiv infection, infection prophylaxis and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: agitation, angiopathy, aphasia, apraxia, areflexia, balance disorder, blood bicarbonate decreased, blood immunoglobulin a increased, blood immunoglobulin g increased. VIREAD dosage: unknown. During the same period patient was treated with CIDOFOVIR, ZIDOVUDINE, LAMIVUDINE, EFAVIRENZ, NEVIRAPINE, DIDANOSINE, LOPINAVIR. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported VIREAD problem on Aug 09, 2006. Female patient, 41 years of age, was diagnosed with asthma, bronchopulmonary aspergillosis allergic and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: depression, impaired gastric emptying. VIREAD dosage: unknown. During the same period patient was treated with VIDEX, VIRAMUNE, SERETIDE, ZITHROMAX, VFEND. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Physician from UNITED KINGDOM on Aug 09, 2006. Male patient, weighting 61.73 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, hypocalcaemia, tetany, urinary incontinence, urine electrolytes increased. VIREAD dosage: unknown. During the same period patient was treated with KALETRA, DIDANOSINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from GERMANY reported VIREAD problem on June 20, 2006. Male patient, weighting 115.1 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: coma hepatic, fanconi syndrome acquired, glycosuria. VIREAD dosage: unknown. During the same period patient was treated with FOSAMPRENAVIR, LAMIVUDINE. Patient died.
VIREAD problem was reported by a Physician from GERMANY on June 14, 2006. Male patient, weighting 136.7 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: ankle fracture, aortic stenosis, blood phosphorus decreased, osteoporosis, renal failure. VIREAD dosage: unknown. During the same period patient was treated with KALETRA, RESCRIPTOR. Patient recovered.
Physician from GERMANY reported VIREAD problem on Aug 09, 2006. Female patient, weighting 187.4 lb, was diagnosed with hiv infection, sleep disorder, oedema, thrombocytopenia and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: osteoporosis, pelvic fracture. VIREAD dosage: unknown. During the same period patient was treated with EMTRIVA, LOPINAVIR, RITONAVIR, ZOPLICONE, METHADONE, SPIRONOLACTONE, PREDNISON. Patient recovered.
VIREAD problem was reported by a Health Professional from FRANCE on Aug 11, 2006. Male patient, 45 years of age, weighting 108.0 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: bone density decreased, fanconi syndrome acquired, hyperphosphaturia. VIREAD dosage: unknown. During the same period patient was treated with VIDEX, NORVIR, EPIVIR. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported VIREAD problem on June 16, 2006. Male patient, weighting 180.8 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood antidiuretic hormone increased, blood creatine phosphokinase increased, muscle injury, myalgia, myoglobin blood increased, myositis. VIREAD dosage: unknown. During the same period patient was treated with ATAZANAVIR, RITONAVIR, DIDANOSINE, SEPTRIN. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Physician from UNITED KINGDOM on July 21, 2006. Male patient, weighting 216.1 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: fanconi syndrome acquired, hypercalcaemia, hyperparathyroidism, hyperphosphaturia, vitamin d deficiency. VIREAD dosage: unknown. During the same period patient was treated with EMTRIVA, RITONAVIR, BEZOLIP MONO, ENTRILITAB INF. Patient recovered.
Consumer or non-health professional from UNITED STATES reported VIREAD problem on Aug 17, 2006. Female patient, 30 years of age, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: congenital anomaly, foetal disorder, pregnancy, ultrasound antenatal screen abnormal. VIREAD dosage: unknown. During the same period patient was treated with DIDANOSINE, ATAZANAVIR, RITONAVIR. Patient recovered.
VIREAD problem was reported by a Health Professional from FRANCE on Aug 18, 2006. Male patient, 52 years of age, weighting 141.1 lb, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: cholestasis, hyperlipidaemia, hypertension, renal infarct, splenic infarction. VIREAD dosage: unknown. During the same period patient was treated with VIDEX, SUSTIVA. Patient recovered.
Health Professional from UNITED KINGDOM reported VIREAD problem on Aug 18, 2006. Male patient, 52 years of age, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: confusional state, granulomatous liver disease, hypercalcaemia, immune reconstitution syndrome, jaundice, pyrexia. VIREAD dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE, ISONIAZID, PYRAZINAMIDE, RIFAMPICIN. Patient recovered.
VIREAD problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Female patient, 30 years of age, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: pregnancy, ultrasound antenatal screen abnormal. VIREAD dosage: unknown. During the same period patient was treated with DIDANOSINE, ATAZANAVIR, RITONAVIR. Patient recovered.
Consumer or non-health professional from GERMANY reported VIREAD problem on Aug 28, 2006. Male patient, weighting 121.3 lb, was diagnosed with hiv infection, candidiasis, oesophageal candidiasis, oedema and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: anaemia, blood creatinine increased, blood potassium increased, blood urea increased, hepatic cirrhosis. VIREAD dosage: unknown. During the same period patient was treated with EPIVIR, KALETRA, RETROVIR, AMPHO, DIFLUCAN, TORSEMIDE, SPIRONOLACTONE, BVKTE. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Consumer or non-health professional from FRANCE on Nov 26, 2002. Male patient, 36 years of age, weighting 88.18 lb, was diagnosed with hiv infection, castleman's disease and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: fanconi syndrome acquired, polydipsia, polyuria, renal tubular disorder. VIREAD dosage: unknown. During the same period patient was treated with VIDEX, NORVIR, EPIVIR, VIRAMUNE, KALETRA, CELLTOP. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported VIREAD problem on Nov 26, 2002. Male patient, 36 years of age, weighting 88.18 lb, was diagnosed with hiv infection, castleman's disease and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood osmolarity increased, blood sodium increased, fanconi syndrome acquired, polydipsia, polyuria, renal tubular disorder, staphylococcal sepsis. VIREAD dosage: unknown. During the same period patient was treated with VIDEX, NORVIR, EPIVIR, VIRAMUNE, KALETRA, CELLTOP. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Physician from UNITED KINGDOM on Aug 09, 2006. Male patient, weighting 61.73 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: hypocalcaemia, hypophosphataemia, tetany, urine electrolytes increased. VIREAD dosage: unknown. During the same period patient was treated with KALETRA, DIDANOSINE. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported VIREAD problem on Sept 19, 2006. Male patient, 53 years of age, weighting 180.8 lb, was diagnosed with depression and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, dialysis, neurological symptom, renal failure acute. VIREAD dosage: unknown. During the same period patient was treated with KALETRA, EPIVIR, EFFEXOR, ATARAX, LEXOMIL. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Physician from GERMANY on Apr 21, 2006. Female patient, weighting 132.3 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: maternal condition affecting foetus, placental disorder. VIREAD dosage: unknown. During the same period patient was treated with KALETRA, TRIZIVIR. Patient died.
Consumer or non-health professional from UNITED KINGDOM reported VIREAD problem on Oct 02, 2006. Male patient, 38 years of age, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: immune reconstitution syndrome, kaposi's sarcoma, lymphoedema. VIREAD dosage: unknown. During the same period patient was treated with LOPINAVIR W, FOSAMPRENAVIR, RITONAVIR. Patient was hospitalized and became disabled. Patient recovered.
VIREAD problem was reported by a Physician from UNITED KINGDOM on Oct 01, 2006. Male patient, 40 years of age, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: blood hiv rna increased, hypophosphataemia, renal impairment. VIREAD dosage: unknown. During the same period patient was treated with BOOSTED ATAZANAVIR, COMBIVIR, GABAPENTIN, ACYCLOVIR. Patient recovered.
Consumer or non-health professional from FRANCE reported VIREAD problem on Mar 29, 2006. Female patient, 61 years of age, weighting 158.7 lb, was diagnosed with hiv infection, prophylaxis, depression and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: blood parathyroid hormone increased, fanconi syndrome acquired, lumbar vertebral fracture, osteomalacia, pelvic fracture, vitamin d decreased. VIREAD dosage: unknown. During the same period patient was treated with EPIVIR, VIRACEPT, PENTACARINAT AEROSOL, EFFEXOR, TERCIAN. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2006. Female patient, 25 years of age, weighting 242.4 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: congenital teratoma, pregnancy. VIREAD dosage: unknown. During the same period patient was treated with VIDEX, VIRACEPT. Patient recovered.
Consumer or non-health professional from UNITED STATES reported VIREAD problem on Oct 26, 2006. Female patient, weighting 6.06 lb, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: congenital teratoma. VIREAD dosage: unknown. During the same period patient was treated with VIDEX, VIRACEPT. Patient recovered.
VIREAD problem was reported by a Pharmacist from UNITED STATES on Nov 13, 2006. Male patient, 55 years of age, weighting 181.8 lb, was diagnosed with acquired immunodeficiency syndrome, hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: renal tubular acidosis. VIREAD dosage: 800MG DAILY PO. During the same period patient was treated with KALETRA, NEURONTIN, GABITRIL, AMITRIPTYLINE, MS CONTIN, CLONAZEPAM. Patient recovered.
Health Professional from FRANCE reported VIREAD problem on Nov 10, 2006. Male patient, 45 years of age, weighting 147.7 lb, was diagnosed with cytomegalovirus infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: abscess neck, aminoaciduria, burning sensation, cytomegalovirus infection, escherichia infection, fanconi syndrome acquired, fistula. VIREAD dosage: unknown. During the same period patient was treated with VISTIDE, EPIVIR, KALETRA, BACTRIM, SYMBICORT, ACETAMINOPHEN W, DIFFU K. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Physician from UNITED KINGDOM on July 21, 2006. Male patient, weighting 216.1 lb, was diagnosed with hiv infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia, hyperglycaemia, hyperparathyroidism tertiary, hypophosphataemia, mediastinal mass, osteopenia, vitamin d deficiency. VIREAD dosage: unknown. During the same period patient was treated with TRUVADA, RITONAVIR, BEZOLIP MONO, ENTRILITAB INF, ATAZANAVIR. Patient recovered.
Physician from UNITED KINGDOM reported VIREAD problem on Sept 22, 2006. Male patient, weighting 138.9 lb, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood phosphorus decreased, bone pain, urinary tract infection. VIREAD dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient recovered.
VIREAD problem was reported by a Health Professional from UNITED KINGDOM on Nov 29, 2006. Male patient, 31 years of age, weighting 125.7 lb, was diagnosed with retroviral infection and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood creatinine increased, blood phosphorus decreased, myopathy, pain in extremity. VIREAD dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient recovered.
Consumer or non-health professional from GERMANY reported VIREAD problem on Aug 28, 2006. Male patient, weighting 121.3 lb, was diagnosed with hiv infection, candidiasis, oesophageal candidiasis, oedema and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood potassium increased, blood urea increased. VIREAD dosage: unknown. During the same period patient was treated with EPIVIR, KALETRA, RETROVIR, AMPHO, DIFLUCAN, TORSEMIDE, SPIRONOLACTONE, BVKTE. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Health Professional from FRANCE on Dec 11, 2006. Male patient, 53 years of age, weighting 119.0 lb, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: motor dysfunction, neuropathy peripheral, paraesthesia. VIREAD dosage: unknown. During the same period patient was treated with FUZEON, PREZISTA, NORVIR, TRIZIVIR, LEDERFOLINE, PYRIMETHAMINE, PENTACARINAT AEROSOL, RIMIFON. Patient recovered.
Health Professional from FRANCE reported VIREAD problem on Dec 12, 2006. Male patient, weighting 110.2 lb, was diagnosed with hiv infection, hepatitis c and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: anaemia, bone pain, gamma-glutamyltransferase increased, lipase increased, muscle atrophy, myalgia, renal failure, renal tubular disorder. VIREAD dosage: unknown. During the same period patient was treated with KALETRA, ZIAGEN, VIRAFERONPEG, CACIT D, ACUPAN, ACETAMINOPHEN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 17, 2007. Male patient, weighting 180.8 lb, was diagnosed with hiv infection, diabetes mellitus and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: anuria, blood chloride decreased, dehydration, diarrhoea, haemodialysis, haemoglobin decreased, hyperkalaemia, lactic acidosis, malaise. VIREAD dosage: unknown. During the same period patient was treated with RITONAVIR, ZIAGEN, METFORMIN, FUZEON, SYNTHROID, AVANDIA, QUININE. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported VIREAD problem on June 21, 2007. Male patient, 50 years of age, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: back pain, blood folate decreased, extrapyramidal disorder, fanconi syndrome acquired, muscular weakness, nerve conduction studies abnormal, osteomalacia, pain in extremity. VIREAD dosage: unknown. During the same period patient was treated with EPIVIR, VIRACEPT. Patient was hospitalized. Patient recovered.
VIREAD problem was reported by a Physician from GERMANY on June 26, 2007. Female patient, weighting 132.3 lb, was diagnosed with hiv infection, hyperlipidaemia and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: anaemia, nausea, polyuria, renal failure acute, rhabdomyolysis, vomiting. VIREAD dosage: unknown. During the same period patient was treated with ZIAGEN, KALETRA, PRAVASTATIN, FENOFIBRAT. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported VIREAD problem on June 22, 2007. Female patient, weighting 165.3 lb, was diagnosed with hiv infection, polyneuropathy, osteoporosis and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, osteoporosis, proteinuria. VIREAD dosage: unknown. During the same period patient was treated with EPIVIR, REYATAZ, GABAPENTIN, CALCIUM CHLORIDE, VITAMIN D3. Patient recovered.
Showing 1-75 of 183 Next >
This
drug has an active FDA Safety Alert